AS MADARA COSMETICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.45 EUR | +1.22% |
|
+1.22% | -17.00% |
| Apr. 26 | AS MADARA Cosmetics Reaffirms Turnover Guidance for the Year 2024 | CI |
| Apr. 26 | AS MADARA Cosmetics Reports Unaudited Consolidated Turnover Results for the First Quarter of 2024 | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 28.09 | 29.77 | 29.4 | 74.63 | 104.1 | 61.51 |
| Enterprise Value (EV) 1 | 24.12 | 26.09 | 26.37 | 69.07 | 97.49 | 55.56 |
| P/E ratio | 22.5 x | 19.6 x | 18.8 x | 21.7 x | 28.4 x | 54.9 x |
| Yield | 1.2% | 1.51% | - | 2.02% | 1.81% | 2.15% |
| Capitalization / Revenue | 3.79 x | 3.12 x | 2.55 x | 4.64 x | 5.37 x | 3.29 x |
| EV / Revenue | 3.26 x | 2.74 x | 2.28 x | 4.3 x | 5.03 x | 2.97 x |
| EV / EBITDA | 13.1 x | 12.8 x | 11.7 x | 16 x | 21.4 x | 20.2 x |
| EV / FCF | 29 x | -61.3 x | -35.7 x | 36.4 x | 75.5 x | 55.3 x |
| FCF Yield | 3.45% | -1.63% | -2.8% | 2.75% | 1.32% | 1.81% |
| Price to Book | 3.87 x | 3.53 x | 3.08 x | 6 x | 7.13 x | 4.45 x |
| Nbr of stocks (in thousands) | 3,745 | 3,745 | 3,745 | 3,769 | 3,771 | 3,774 |
| Reference price 2 | 7.500 | 7.950 | 7.850 | 19.80 | 27.60 | 16.30 |
| Announcement Date | 5/10/18 | 5/14/19 | 7/14/20 | 5/26/21 | 6/21/22 | 5/26/23 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 7.402 | 9.529 | 11.55 | 16.07 | 19.37 | 18.7 |
| EBITDA 1 | 1.845 | 2.037 | 2.264 | 4.318 | 4.548 | 2.749 |
| EBIT 1 | 1.429 | 1.538 | 1.556 | 3.619 | 3.904 | 1.655 |
| Operating Margin | 19.31% | 16.14% | 13.48% | 22.51% | 20.16% | 8.85% |
| Earnings before Tax (EBT) 1 | 1.329 | 1.517 | 1.563 | 3.563 | 4.014 | 1.554 |
| Net income 1 | 1.246 | 1.517 | 1.563 | 3.445 | 3.669 | 1.121 |
| Net margin | 16.83% | 15.91% | 13.54% | 21.43% | 18.94% | 5.99% |
| EPS 2 | 0.3327 | 0.4049 | 0.4174 | 0.9140 | 0.9730 | 0.2970 |
| Free Cash Flow 1 | 0.8319 | -0.4255 | -0.7391 | 1.899 | 1.291 | 1.005 |
| FCF margin | 11.24% | -4.47% | -6.4% | 11.81% | 6.66% | 5.38% |
| FCF Conversion (EBITDA) | 45.09% | - | - | 43.97% | 28.38% | 36.58% |
| FCF Conversion (Net income) | 66.76% | - | - | 55.12% | 35.19% | 89.7% |
| Dividend per Share 2 | 0.0900 | 0.1200 | - | 0.4000 | 0.5000 | 0.3500 |
| Announcement Date | 5/10/18 | 5/14/19 | 7/14/20 | 5/26/21 | 6/21/22 | 5/26/23 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S1 | 2019 S2 | 2022 S1 | 2022 S2 |
|---|---|---|---|---|
| Net sales 1 | 5.59 | 5.955 | 10.21 | 8.472 |
| EBITDA 1 | 1.112 | 1.088 | - | 0.896 |
| EBIT 1 | 0.7767 | 0.7159 | - | 0.3165 |
| Operating Margin | 13.89% | 12.02% | - | 3.74% |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income | - | - | - | - |
| Net margin | - | - | - | - |
| EPS | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 8/28/19 | 2/26/20 | 8/22/22 | 2/28/23 |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 3.97 | 3.68 | 3.03 | 5.56 | 6.58 | 5.95 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 0.83 | -0.43 | -0.74 | 1.9 | 1.29 | 1.01 |
| ROE (net income / shareholders' equity) | 24.6% | 19.3% | 17.4% | 31.4% | 27.2% | 7.89% |
| ROA (Net income/ Total Assets) | 13.1% | 10.1% | 9.32% | 17.9% | 15.8% | 6.28% |
| Assets 1 | 9.494 | 14.96 | 16.77 | 19.2 | 23.22 | 17.86 |
| Book Value Per Share 2 | 1.940 | 2.250 | 2.550 | 3.300 | 3.870 | 3.660 |
| Cash Flow per Share 2 | 1.090 | 0.9100 | 0.6200 | 1.500 | 1.750 | 1.580 |
| Capex 1 | 0.44 | 1.14 | 1.19 | 0.73 | 1.8 | 1.51 |
| Capex / Sales | 6% | 11.96% | 10.28% | 4.54% | 9.29% | 8.06% |
| Announcement Date | 5/10/18 | 5/14/19 | 7/14/20 | 5/26/21 | 6/21/22 | 5/26/23 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -17.00% | 50.2M | |
| -3.33% | 249B | |
| +10.09% | 18.86B | |
| 0.00% | 17.37B | |
| -1.32% | 10.65B | |
| -7.73% | 10.26B | |
| +3.86% | 6.72B | |
| +9.76% | 5.94B | |
| -0.06% | 4.55B | |
| -16.98% | 3.83B |
- Stock Market
- Equities
- MDARA Stock
- Financials AS MADARA Cosmetics
